Nihon Kohden Corporation operates within the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nihon Kohden with three other medical equipment manufacturers in Asia: Japan Lifeline Co., Ltd. (2018 sales of 42.30 billion Japanese Yen [US$377.72 million] of which 48% was EP/Application), Fukuda Denshi Co., Ltd. (128.88 billion Japanese Yen [US$1.15 billion] of which 39% was Treatment Equipment), and Microport Scientific Corp which is based in China (4.43 billion Chinese Renmimbi [US$660.45 million] ).

Sales Analysis. During the year ended March of 2018, sales at Nihon Kohden were ¥174.25 billion (US$1.56 billion). This is an increase of 4.8% versus 2017, when the company's sales were ¥166.29 billion. This was the fifth consecutive year of sales increases at Nihon Kohden (and since 2013, sales have increased a total of 31%). Sales of Treatment Equipment saw an increase that was more than double the company's growth rate: sales were up 10.6% in 2018, from ¥29.73 billion to ¥32.89 billion.